RecruitingPhase 3NCT07028853This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.Sponsor: PfizerBala-Cynwyd, PA · Lancaster, PA · +125 more sites
RecruitingPhase 2NCT07745361Study of Oral MRT-2359 With Apalutamide in Prostate CancerSponsor: Monte Rosa Therapeutics, IncLancaster, PA · +13 more sites
RecruitingPhase 3NCT07164443A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)Sponsor: Janssen Research & Development, LLCBala-Cynwyd, PA · Lancaster, PA · Philadelphia, PA · +51 more sites
RecruitingPhase 1NCT05413421Study of ORIC-944 in Patients With Metastatic Prostate CancerSponsor: ORIC PharmaceuticalsBala-Cynwyd, PA · Lancaster, PA · +18 more sites
RecruitingPhase 2NCT06134232Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-TSponsor: DendreonBala-Cynwyd, PA · Lancaster, PA · +29 more sites